
FDA granted accelerated approval to belantamab mafodotin-blmf for multiple myeloma
The Food and Drug Administration (FDA) approved belantamab mafodotin-blmf for adult patients with relapsed or…
The Food and Drug Administration (FDA) approved belantamab mafodotin-blmf for adult patients with relapsed or…